Urine-derived induced pluripotent stem cells as a modeling tool for paroxysmal kinesigenic dyskinesia

Biology Open

Volumn 4, Issue 12, 2015, Pages 1744-1752

  Zhang, Shu Zhen ^a   Li, Hong Fu ^b   Ma, Li Xiang ^a   Qian, Wen Jing ^a   Wang, Zhong Feng ^a   Wu, Zhi Ying ^b  

^a FUDAN UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Human induced pluripotent stem cells; Paroxysmal kinesigenic dyskinesia; Proline rich transmembrane protein 2

Indexed keywords

SODIUM CHANNEL; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ECTODERM; ENDODERM; INDUCED PLURIPOTENT STEM CELL; MESODERM; MOTONEURON; MOUSE; NONHUMAN; PAROXYSMAL KINESIGENIC DYSKINESIA; PATHOGENESIS;

EID: 84982854605     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.013078     Document Type: Article

References (47)

1. Aasen, T., Raya, A., Barrero, M. J., Garreta, E., Consiglio, A., Gonzalez, F., Vassena, R., Bilić, J., Pekarik, V., Tiscornia, G. et al. (2008). Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26, 1276-1284.
2. Allodi, I. and Hedlund, E. (2014). Directed midbrain and spinal cord neurogenesis from pluripotent stem cells to model development and disease in a dish. Front. Neurosci. 8, 109.
3. Bruno, M. K., Hallett, M., Gwinn-Hardy, K., Sorensen, B., Considine, E., Tucker, S., Lynch, D. R., Mathews, K. D., Swoboda, K. J., Harris, J. et al. (2004). Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology 63, 2280-2287.
4. Cai, C., Shi, O. and Li, W. D. (2012). Missense mutations of the proline-rich transmembrane protein 2 gene cosegregate with mild paroxysmal kinesigenic dyskinesia and infantile convulsions in a Chinese pedigree. Parkinsonism Relat. Disord. 19, 402-403.
5. Chen, W.-J., Lin, Y., Xiong, Z.-Q., Wei, W., Ni, W., Tan, G.-H., Guo, S.-L., He, J., Chen, Y.-F., Zhang, Q.-J. et al. (2011). Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat. Genet. 43, 1252-1255.
6. de Vries, B., Callenbach, P. M. C., Kamphorst, J. T., Weller, C. M., Koelewijn, S. C., Houten, R. T., de Coo, I. F. M., Brouwer, O. F. and van den Maagdenberg, A. M. J. M. (2012). PRRT2 mutation causes benign familial infantile convulsions. Neurology 79, 2154-2155.
7. Deadwyler, S. A., Hampson, R. E., Mu, J., Whyte, A. and Childers, S. (1995). Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J. Pharmacol. Exp. Ther. 273, 734-743.
8. Esteban, M. A., Wang, T., Qin, B., Yang, J., Qin, D., Cai, J., Li, W., Weng, Z., Chen, J., Ni, S. et al. (2010). Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6, 71-79.
9. Fourcade, G., Roubertie, A., Doummar, D., Vidailhet, M. and Labauge, P. (2009). [Paroxysmal kinesigenic dyskinesia: a channelopathy? Study of 19 cases]. Rev. Neurol. 165, 164-169.
10. Guerrini, R. and Mink, J. W. (2012). Paroxysmal disorders associated with PRRT2 mutations shake up expectations on ion channel genes. Neurology 79, 2086-2088.
11. Heron, S. E. and Dibbens, L. M. (2013). Role of PRRT2 in common paroxysmal neurological disorders: a gene with remarkable pleiotropy. J. Med. Genet. 50, 133-139.
12. Heron, S. E., Grinton, B. E., Kivity, S., Afawi, Z., Zuberi, S. M., Hughes, J. N., Pridmore, C., Hodgson, B. L., Iona, X., Sadleir, L. G. et al. (2012). PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am. J. Hum. Genet. 90, 152-160.
13. Hu, B.-Y. and Zhang, S.-C. (2010). Directed differentiation of neural-stem cells and subtype-specific neurons from hESCs. Methods Mol. Biol. 636, 123-137.
14. Imaizumi, Y. and Okano, H. (2014). Modeling human neurological disorders with induced pluripotent stem cells. J. Neurochem. 129, 388-399.
15. Isobe, K.-I., Cheng, Z., Nishio, N., Suganya, T., Tanaka, Y. and Ito, S. (2014). iPSCs, aging and age-related diseases. New Biotechnol. 31, 411-421.
16. Lee, H.-Y., Huang, Y., Bruneau, N., Roll, P., Roberson, E. D. O., Hermann, M., Quinn, E., Maas, J., Edwards, R., Ashizawa, T. et al. (2012a). Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep. 1, 2-12.
17. Lee, Y.-C., Lee, M.-J., Yu, H.-Y., Chen, C., Hsu, C.-H., Lin, K.-P., Liao, K.-K., Chang, M.-H., Liao, Y.-C. and Soong, B.-W. (2012b). PRRT2 mutations in paroxysmal kinesigenic dyskinesia with infantile convulsions in a Taiwanese cohort. PLoS ONE 7, e38543.
18. Li, X.-J., Du, Z.-W., Zarnowska, E. D., Pankratz, M., Hansen, L. O., Pearce, R. A. and Zhang, S.-C. (2005). Specification of motoneurons from human embryonic stem cells. Nat. Biotechnol. 23, 215-221.
19. Li, X.-J., Zhang, X., Johnson, M. A., Wang, Z.-B., LaVaute, T. and Zhang, S.-C. (2009). Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development 136, 4055-4063.
20. Li, J., Zhu, X., Wang, X., Sun, W., Feng, B., Du, T., Sun, B., Niu, F., Wei, H., Wu, X. et al. (2012). Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis. J. Med. Genet. 49, 76-78.
21. Li, H.-F., Ni, W., Xiong, Z.-Q., Xu, J. and Wu, Z.-Y. (2013a). PRRT2 c.649dupC mutation derived from de novo in paroxysmal kinesigenic dyskinesia. CNS Neurosci. Ther. 19, 61-65.
22. Li, H.-F., Chen, W.-J., Ni, W., Wang, K.-Y., Liu, G.-L., Wang, N., Xiong, Z.-Q., Xu, J. and Wu, Z.-Y. (2013b). PRRT2 mutation correlated with phenotype of paroxysmal kinesigenic dyskinesia and drug response. Neurology 80, 1534-1535.
23. Liu, Y., Liu, H., Sauvey, C., Yao, L., Zarnowska, E. D. and Zhang, S.-C. (2013a). Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells. Nat. Protoc. 8, 1670-1679.
24. Liu, Y., Weick, J. P., Liu, H., Krencik, R., Zhang, X., Ma, L., Zhou, G.-M., Ayala, M. and Zhang, S.-C. (2013b). Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits. Nat. Biotechnol. 31, 440-447.
25. Loh, Y.-H., Hartung, O., Li, H., Guo, C., Sahalie, J. M., Manos, P. D., Urbach, A., Heffner, G. C., Grskovic, M., Vigneault, F. et al. (2010). Reprogramming of T cells from human peripheral blood. Cell Stem Cell 7, 15-19.
26. Luo, C., Chen, Y., Song, W., Chen, Q., Gong, Q. and Shang, H.-F. (2013). Altered intrinsic brain activity in patients with paroxysmal kinesigenic dyskinesia by PRRT2 mutation: altered brain activity by PRRT2 mutation. Neurol. Sci. 34, 1925-1931.
27. Ma, L., Liu, Y. and Zhang, S.-C. (2011). Directed differentiation of dopamine neurons from human pluripotent stem cells. Methods Mol. Biol. 767, 411-418.
28. Ma, L., Hu, B., Liu, Y., Vermilyea, S. C., Liu, H., Gao, L., Sun, Y., Zhang, X. and Zhang, S.-C. (2012). Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. Cell Stem Cell 10, 455-464.
29. Perrier, A. L., Tabar, V., Barberi, T., Rubio, M. E., Bruses, J., Topf, N., Harrison, N. L. and Studer, L. (2004). Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 101, 12543-12548.
30. Ruggieri, M., Riboldi, G., Brajkovic, S., Bucchia, M., Bresolin, N., Comi, G. P. and Corti, S. (2014). Induced neural stem cells: methods of reprogramming and potential therapeutic applications. Prog. Neurobiol. 114, 15-24.
31. Seki, T., Yuasa, S. and Fukuda, K. (2012). Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus. Nat. Protoc. 7, 718-728.
32. Shimada, T., Takai, Y., Shinohara, K., Yamasaki, A., Tominaga-Yoshino, K., Ogura, A., Toi, A., Asano, K., Shintani, N., Hayata-Takano, A. et al. (2012). A simplified method to generate serotonergic neurons from mouse embryonic stem and induced pluripotent stem cells. J. Neurochem. 122, 81-93.
33. Song, B., Niclis, J. C., Alikhan, M. A., Sakkal, S., Sylvain, A., Kerr, P. G., Laslett, A. L., Bernard, C. A. and Ricardo, S. D. (2011). Generation of induced pluripotent stem cells from human kidney mesangial cells. J. Am. Soc. Nephrol. 22, 1213-1220.
34. Staerk, J., Dawlaty, M. M., Gao, Q., Maetzel, D., Hanna, J., Sommer, C. A., Mostoslavsky, G. and Jaenisch, R. (2010). Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 7, 20-24.
35. Sun, N., Panetta, N. J., Gupta, D. M., Wilson, K. D., Lee, A., Jia, F., Hu, S., Cherry, A. M., Robbins, R. C., Longaker, M. T. et al. (2009). Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc. Natl. Acad. Sci. USA 106, 15720-15725.
36. Surmacz, B., Fox, H., Gutteridge, A., Lubitz, S. and Whiting, P. (2012). Directing differentiation of human embryonic stem cells toward anterior neural ectoderm using small molecules. Stem Cells 30, 1875-1884.
37. Takahashi, K. and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
38. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
39. Utikal, J., Maherali, N., Kulalert, W. and Hochedlinger, K. (2009). Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J. Cell Sci. 122, 3502-3510.
40. van Rootselaar, A.-F., van Westrum, S. S., Tijssen, M. A. J. and Velis, D. N. (2009). The paroxysmal dyskinesias. Pract. Neurol. 9, 102-109.
41. Wang, J.-L., Cao, L., Li, X.-H., Hu, Z.-M., Li, J.-D., Zhang, J.-G., Liang, Y., San, A., Li, N., Chen, S.-Q. et al. (2011). Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain 134, 3493-3501.
42. Wang, L., Wang, L., Huang, W., Su, H., Xue, Y., Su, Z., Liao, B., Wang, H., Bao, X., Qin, D. et al. (2013). Generation of integration-free neural progenitor cells from cells in human urine. Nat. Methods 10, 84-89.
43. Waschek, J. A. (2012). Noggin on heaven's door: a factor that promotes the selective production of serotonergic neurons from murine embryonic stem cells and induced pluripotent stem cells. J. Neurochem. 122, 1-3.
44. Wichterle, H., Lieberam, I., Porter, J. A. and Jessell, T. M. (2002). Directed differentiation of embryonic stem cells into motor neurons. Cell 110, 385-397.
45. Yan, Y., Yang, D., Zarnowska, E. D., Du, Z., Werbel, B., Valliere, C., Pearce, R. A., Thomson, J. A. and Zhang, S.-C. (2005). Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 23, 781-790.
46. Zhang, X.-Q. and Zhang, S.-C. (2010). Differentiation of neural precursors and dopaminergic neurons from human embryonic stem cells. Methods Mol. Biol. 584, 355-366.
47. Zhou, T., Benda, C., Dunzinger, S., Huang, Y., Ho, J. C., Yang, J., Wang, Y., Zhang, Y., Zhuang, Q., Li, Y. et al. (2012). Generation of human induced pluripotent stem cells from urine samples. Nat. Protoc. 7, 2080-2089.